Adarshlata Singh

Department of Dermatology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, (Deemed to be University) Wardha, Maharashtra, India

Publications

Review Article
Denovo Diabetes Mellitus among Patients of COVID-19
Author(s): Tanvi Banait*, Pankaj Wagh, Adarshlata Singh, Saiprasath Janaarthanan, Shashank Banait and Jyoti Jain

There are increasing evidence that coronavirus disease-19 (COVID-19) can lead to development of denovo diabetes mellitus (DM) (new onset DM). It has also been observed during last 21 months that there is a bidirectional relationship between COVID-19 and DM. On the one hand, pre-existing diabetic patients has an increased risk of severe COVID-19 disease, intensive care unit (ICU) admissions, need for mechanical ventilation, severe metabolic complications and high doses of insulin requirement. It is an independent predictor of mortality in COVID-19 patients. On the other hand, development of fasting hyperglycaemia and acute-onset denovo DM, have been observed and reported among patients with Covid-19. Various postulated mechanism for development of denovo DM are direct virus-mediated beta-cell damage by angiotensin converting enzyme (ACE) receptor present in endocrine pancreas, triggeri.. Read More»

Abstract HTML PDF